Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kerry Pearson

Optometrist Mesa, AZ Doctor of Optometry

NPI 1265455034 CMS profile 238246

1649 S Stapley Dr, Ste 108, Mesa, AZ 85204

Open in the dashboard

General payments

$9,943

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kerry Pearson of Mesa, AZ is reported in the CMS Open Payments database as having received $9,943 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $368 4
2024 General $445 3
2023 General $152 3
2022 General $481 4
2021 General $653 8
2020 General $323 13
2019 General $7,521 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kerry Pearson
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Kerry Pearson were reported at $368. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Kerry Pearson Optometrist median Middle half National median
2019 $7,521 $159 $67–$371 $163
2020 $323 $72 $29–$165 $114
2021 $653 $125 $46–$292 $132
2022 $481 $162 $66–$374 $149
2023 $152 $177 $72–$406 $160
2024 $445 $188 $77–$427 $164
2025 $368 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $5,316 34 payments
  2. Alcon Vision LLC $2,371 9 payments
  3. TissueTech, Inc. $769 6 payments
  4. Johnson & Johnson Vision Care, Inc. $706 18 payments
  5. NotalVision $257 1 payment
  6. Bausch & Lomb, a division of Bausch Health US, LLC $211 2 payments
  7. Sight Sciences, Inc. $149 1 payment
  8. Oyster Point Pharma, Inc. $127 1 payment
  9. ABB Con-Cise Optical Group LLC $18 1 payment
  10. Allergan Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,167 11 payments
  2. Food and Beverage $3,276 62 payments
  3. Consulting Fee $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Clariti Contact Lens $3,414 23 payments
  2. DAILIES $2,371 9 payments
  3. Multiple Brands Contact Lens $1,500 1 payment
  4. Acuvue $584 17 payments
  5. MyDay Contact Lens $255 4 payments
  6. PROKERA $240 2 payments
  7. AMNIOGRAFT $240 2 payments
  8. INFUSE $211 2 payments
  9. TearCare SmartLid $149 1 payment
  10. TEARCARE(TM) (2.2) SYSTEM KIT $149 1 payment
  11. Other $428 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$3,770

Medicare's payments for the services billed

Medicare patients

52

Average age 75

Services billed

78

26 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 63%
Arthritis 48%
Ischemic heart disease 29%
Chronic kidney disease 25%
Diabetes 21%
Atrial fibrillation 21%
Cancer 21%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record